InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,246.68
(
0.48%
)
US TECH 100
17,844.00
(
0.68%
)
Dow Jones
39,558.11
(
0.32%
)
Brent Oil
82.64
(
0.10%
)
Bitcoin
61,738.16
(
0.31%
)
Post# of 7387
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

biotech_researcher

Send PM Follow Ignore
Followers 82
Posts 12435
Boards Moderated 0
Alias Born 07/25/2008

biotech_researcher

Re: None

Wednesday, 09/12/2018 3:51:21 PM

Wednesday, September 12, 2018 3:51:21 PM

Post# of 7387
With all the announced and unannounced indications for R002, I expect it is more important than ever that Revance be taken out by a big pharma entity to accelerate R002’s development.

More wishful thinking I suppose on my part..
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent RVNC News
More RVNC News
InvestorsHub NewsWire

FEATURED POET Announces Design Win and Collaboration with Foxconn Interconnect Technology for High-speed AI Systems • May 14, 2024 10:09 AM

FEATURED Element79 Gold Corp Reports Exceptionally High-Grade Results from Lucero • May 14, 2024 7:00 AM

VAYK Added New Manager for Expansion into $64 Billion Domestic Short-term Rental Market • VAYK • May 14, 2024 9:00 AM

Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM

VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM

Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM

Start posting your company's news
Only $200 per official company press release!